Search
02/09/2025
Propofol-based versus sevoflurane-based anaesthesia for deceased donor kidney transplantation: the VAPOR-2 study protocol for an international multicentre randomised controlled trial
Huisman, GJJ, Berger, SP, Thyrrestrup, PS, Hausken, J, Veelo, DP, Guirado, L, Pol, R, Jensen, LL, Tonnessen, TI, Bemelman, FJ, Facundo, C, Tamasi, K, Lunter, G, Jespersen, B, Leuvenink, HGD, Struys, MMRF, Nieuwenhuijs-Moeke, GJ. Propofol-based versus sevoflurane-based anaesthesia for deceased donor kidney transplantation: the VAPOR-2 study protocol for an international multicentre randomised controlled trial. BMJ Open. 2025; 15(9)DOI:10.1136/bmjopen-2025-098965. PMID:40897490. IF:2.300(Q2/3D).
01/09/2025
European Stroke Organisation (ESO) standard operating procedure for white papers (expert consensus based clinical guidance)
de Sousa, DA, Zietz, A, Zedde, M, Katsanos, AH, Li, LX, Marti-Fabregas, J, Nolte, CH, Podlasek, A, Poli, S, Purrucker, J, Roaldsen, MB, Schellinger, PD, Strbian, D, Tsivgoulis, G, Tsokani, S, Veroniki, AA, Quinn, TJ. European Stroke Organisation (ESO) standard operating procedure for white papers (expert consensus based clinical guidance). European Stroke Journal. 2025; 10(3)DOI:10.1177/23969873251316430. PMID:39904756. IF:4.500(Q1/2D).
01/09/2025
282nd ENMC international workshop-standards of diagnosis and care for the sarcoglycanopathies. 8-10 November 2024, Amsterdam, Netherlands
Iammarino, MA, Alonso-Perez, J, Stojkovic, T, Pegoraro, E, Lowes, L, Diaz-Manera, J. 282nd ENMC international workshop-standards of diagnosis and care for the sarcoglycanopathies. 8-10 November 2024, Amsterdam, Netherlands. NEUROMUSCULAR DISORDERS. 2025; 54DOI:10.1016/j.nmd.2025.106212. PMID:40997622. IF:2.800(Q2/5D).
01/09/2025
Real-World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape
Querol, L, Rinaldi, S, Borsi, A, Boggia, GM, de Courcy, J, Taylor, Y, Wright, J, Karmous, W, Noel, W, Gary, C, zu Hörste, GM. Real-World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:10.1111/jns.70047. PMID:40826893. IF:3.200(Q2/4D).
01/09/2025
Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain
de Frutos, F, Herrador, L, Peiró-Aventin, B, Eiros, R, Freire, JL, Zorio, E, Carbayo, A, Llongueras-Espi, P, Garcia-Alvarez, A, Ripoll-Vera, T, Macias, R, Vilches, S, Ruiz-Bustillo, S, Arana-Achaga, X, Ordás, JG, Piqueras-Flores, J, Ruiz-Cueto, M, Casasnovas, C, Tirón, C, Rojas-Garcia, R, Sevilla, T, Rodriguez-Palomares, JF, González-López, E, Villacorta, E, Garcia-Pavia, P, González-Costello, J. Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(9)DOI:10.1016/j.rec.2024.12.012. PMID:39827963. IF:4.900(Q1/2D).
01/09/2025
Correspondence to: Use of levodopa-carbidopa intestinal gel to treat patients with multiple system atrophy
Lopes, S, Fonseca, V, Pascual-Sedano, B, Simoes, R, Varanda, S, Pagonabarraga, J, Campolongo, A, Rodrigues, M. Correspondence to: Use of levodopa-carbidopa intestinal gel to treat patients with multiple system atrophy. PARKINSONISM & RELATED DISORDERS. 2025; 138DOI:10.1016/j.parkreldis.2025.107966. PMID:40763399. IF:3.400(Q2/3D).